NEW YORK (GenomeWeb) – In a filing with US Securities and Exchange Commission last week, Genomic Health disclosed that it is being investigated by the United States Department of Justice related to its compliance with the Medicare Date of Service billing regulation.
According to the firm's 10-Q report, Genomic Health received a civil investigative demand in connection with the matter, and said it "has produced specific documents in response to the CID."